Dafodil
Dafodil Pericardial Bioprosthesis - Aortic
Heart ValvesMeril Life Sciences
Tri-leaflet stented bioprosthesis designed for aortic valve replacement with triple-composite design providing optimal Effective Orifice Area (EOA). Features bovine pericardium tissue with proprietary anti-calcification treatment and Elgiloy alloy wireform for superior radio-opacity and handling characteristics.
Product overview
Tri-leaflet stented bioprosthesis designed for aortic valve replacement with triple-composite design providing optimal Effective Orifice Area (EOA). Features bovine pericardium tissue with proprietary anti-calcification treatment and Elgiloy alloy wireform for superior radio-opacity and handling characteristics.
Technical specifications
| storage temperature | 10°C to 25°C (50-77°F) |
| storage solution | Glutaraldehyde |
| rinse procedure | 1 min rinse each in first 3 bowls and store valve in 4th bowl prior to implantation |
| mri safety | MR conditional tested at 1.5 and 3.0 Tesla |
| design | Triple-composite design with triad frame |
| material | Bovine pericardium with Elgiloy alloy wireform |
| leaflets | Three independent pericardial leaflets laser cut for uniformity |
| frame design | Triad-frame with superior spring efficiency, fatigue and corrosion resistance |
Clinical scope
Procedures
- • Aortic Valve Replacement
- • AVR
Anatomical focus
- • Aortic Valve
- • Aortic Position
Indications & use cases
Stented BioprosthesisTri-leaflet DesignTriple-Composite ConstructionMR ConditionalAnti-CalcificationElgiloy WireformOptimal EOA
Surgical Decision Engine
Cross-sell intelligence powered by product knowledge graph